...
首页> 外文期刊>Neurosurgical review. >Intra-procedural complications, success rate, and need for retreatment of endovascular treatments in anterior communicating artery aneurysms: a systematic review and meta-analysis
【24h】

Intra-procedural complications, success rate, and need for retreatment of endovascular treatments in anterior communicating artery aneurysms: a systematic review and meta-analysis

机译:前交通动脉瘤术中并发症、成功率和血管内治疗的再治疗需求:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

In recent years, intracranial aneurysms have been widely treated with endovascular methods. The anterior communicating artery (Acom) is the most common site of intracranial aneurysms. Despite its effectiveness, endovascular interventions can be associated with various intra-procedural and post-procedural complications. A systematic review of the literature was performed through PubMed, Embase, Scopus, and Web of Sciences databases up to March 18, 2022. The pooled rates of intra-procedural complications, mortality, procedure-related morbidities, the immediate and late aneurysm occlusion, and also the necessity for retreatment were calculated by applying random-effects models. A total of 41 articles with 4583 patients were included in the meta-analysis. The pooled rate of overall intra-procedural complications was 9.6 (95 CI: 7.7 to 11.8). The initial rupture status and also type of EVT procedure did not affect the overall complication rate. The pooled rate of intra-procedural thrombosis, aneurysm rupture, coil prolapse, and early aneurysm rebleeding were 6.1 (95 CI: 4.5 to 8.2); 4.2 (95 CI: 3.4 to 5.2), 4.7 (95 CI: 3.2 to 6.7), and 2.2 (95 CI: 1.5 to 3.2), respectively. Our analysis showed that intra-procedural mortality occurred in 1.7 (95 CI: 1.1 to 2.5) and procedure-related permanent morbidities in 3.3 (95 CI: 2.3 to 4.7) of patients. Endovascular methods achieved complete and near to complete aneurysm occlusion (Raymond-Roy occlusion classification 1 and 2) in 89.2 (95 CI: 86.4 to 92.5) of cases post-procedure, and 9.5 (95 CI: 7.3 to 12.4) of patients needed retreatment due to recanalization in follow-ups. Endovascular treatment can serve as an acceptable method for Acom aneurysms. However, improved endovascular treatment equipment and new techniques provide more satisfactory outcomes for complicated cases.
机译:近年来,颅内动脉瘤已被广泛采用血管内方法治疗。前交通动脉 (Acom) 是颅内动脉瘤最常见的部位。尽管其有效性,但血管内介入治疗可能与各种术中和术后并发症有关。截至 2022 年 3 月 18 日,通过 PubMed、Embase、Scopus 和 Web of Sciences 数据库对文献进行了系统评价。通过应用随机效应模型计算术中并发症、死亡率、手术相关发病率、即刻和晚期动脉瘤闭塞以及再治疗必要性的合并率。荟萃分析共纳入41篇文章,涉及4583名患者。总体术中并发症的合并率为9.6%(95%CI:7.7-11.8%)。初始破裂状态和EVT手术类型不影响总体并发症发生率。术中血栓形成、动脉瘤破裂、弹簧圈脱垂和早期动脉瘤再出血的合并率为6.1%(95%CI:4.5-8.2%);分别为 4.2%(95% CI:3.4-5.2%)、4.7%(95% CI:3.2-6.7%)和 2.2%(95% CI:1.5-3.2%)。我们的分析显示,术中死亡率发生率为1.7%(95%CI:1.1-2.5%),手术相关永久性并发症发生率为3.3%(95%CI:2.3-4.7%)。89.2%(95% CI:86.4-92.5%)的术后病例采用血管内方法实现了完全和接近完全动脉瘤闭塞(Raymond-Roy 闭塞分类 1 和 2),9.5%(95% CI:7.3-12.4%)的患者因随访中再通而需要再次治疗。血管内治疗可以作为 Acom 动脉瘤的可接受方法。然而,改进的血管内治疗设备和新技术为复杂病例提供了更令人满意的结果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号